33620 Results

People

  1. Ladanyi
    Ladanyi
  2. Giralt
    Giralt
  3. Motzer
    Motzer
  4. Reuter
    Reuter
  5. Perales
    Perales
  6. Scher
    Scher
  7. Zelenetz
    Zelenetz
  8. Berger
    Berger
  9. Al-Ahmadie
    Al-Ahmadie
  10. O'Reilly
    O'Reilly

Groups

  1. Department of Medicine (15822)
  2. Solid Tumor Oncology Division (9435)
  3. GSK Faculty (7076)
  4. Hematologic Malignancies, Division of (6210)
  5. Center for Hematologic Malignancies (6017)
  6. Survivorship Research (5192)
  7. Department of Pathology and Laboratory Medicine (5172)
  8. Surgery (4871)
  9. Sloan Kettering Institute Faculty (3826)
  10. Sloan Kettering Institute Postdocs (3612)
  1. "Meeting abstract"
Formats
  1. Meeting Abstract (33620)
Groups
  1. Department of Medicine (15822)
  2. Solid Tumor Oncology Division (9435)
  3. GSK Faculty (7076)
  4. Hematologic Malignancies, Division of (6210)
  5. Center for Hematologic Malignancies (6017)
  6. Survivorship Research (5192)

More Groups

People
  1. Marc Ladanyi (641)
  2. Sergio Giralt (632)
  3. Robert Motzer (574)
  4. Victor Reuter (568)
  5. Miguel-Angel Perales (482)
  6. Howard Scher (463)

More People

Years
  1. 2025 (295)
  2. 2024 (1694)
  3. 2023 (1954)
  4. 2022 (2196)
  5. 2021 (1731)
  6. 2020 (1901)

More Years

Publications
  1. Journal of Clinical Oncology (6252)
  2. Blood (3939)
  3. Laboratory Investigation (1846)
  4. Cancer Research (1822)
  5. International Journal of Radiation Oncology, Biology, Physics (1643)
  6. Modern Pathology (1494)

More Publications

Publishers
  1. American Society of Clinical Oncology (6251)
  2. Elsevier Inc. (4694)
  3. American Society of Hematology (3939)
  4. American Association for Cancer Research (3045)
  5. Nature Publishing Group (2151)
  6. Oxford University Press (2096)

More Publishers

Results (33620)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • National Comprehensive Cancer Network (NCCN) infusion efficiency workgroup study: Optimizing patient flow in infusion centers
    Meeting Abstract

    Sugalski, J.; Mulkerin, D.; Caires, R.; Moore, P. J.; Fiorarancio Fahy, R.; Gordon, J. N.; Augustyniak, C. Z.; Szymanski, G. M.; Olsen, M. M.; Frantz, D. K.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Treatment of metastatic human papillomavirus-associated epithelial cancers with adoptive transfer of tumor-infiltrating T cells
    Meeting Abstract

    Stevanovic, S.; Helman, S. R.; Wunderlich, J. R.; Langhan, M. M.; Doran, S. L.; Kwong, M. L. M.; Somerville, R. P.; Klebanoff, C. A.; Kammula, U.; Sherry, R. M.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Local drug activation technology to make cytotoxics safer for localized solid tumors
    Meeting Abstract

    Srinivasan, S.; Yee, N.; Dela Cruz, F.; Kung, A.; Gaviria, E.; Miller, E.; Royzen, M.; Oneto, J. M. M.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Exploring effects of MEK inhibition in tumor microenvironment in non-small cell lung cancer (NSCLC) pre-clinical models
    Meeting Abstract

    Silk, T.; Choi, H.; Deng, J.; Pourpe, S.; Wong, K. K.; Merghoub, T.; Wolchok, J. D.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Indirect treatment comparison of nivolumab versus placebo as an adjuvant therapy for resected melanoma
    Meeting Abstract

    Shoushtari, A. N.; Freeman, M. L.; Betts, K. A.; Gupte-Singh, K.; Du, E. X.; Ritchings, C.; Rao, S.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • A multicenter, randomized, controlled trial comparing the occurrence of major adverse cardiovascular events (MACEs) in patients (pts) with prostate cancer (pc) and cardiovascular disease (CVD) receiving degarelix (GnRH receptor antagonist) or leuprolide (GnRH receptor agonist)
    Meeting Abstract

    Slovin, S. F.; Melloni, C.; Mansor-Lefebvre, S.; Neijber, A.; Roe, M.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Predicting disease progression in patients (pts) with nonmetastatic castration-resistant prostate cancer (nmCRPC): An analysis from the phase 3 SPARTAN trial
    Meeting Abstract

    Small, E. J.; Saad, F.; Rathkopf, D. E.; Hadaschik, B. A.; Chowdhury, S.; Yu, M. K.; Lopez-Gitlitz, A.; Rooney, O. B.; Shu, Y.; Darif, M.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Relationship of time to metastasis (TTM) and site of metastases in patients (pts) with nonmetastatic castration-resistant prostate cancer (nmCRPC): Results from the phase 3 SPARTAN trial
    Meeting Abstract

    Smith, M. R.; Saad, F.; Rathkopf, D. E.; Hadaschik, B. A.; Chowdhury, S.; Yu, M. K.; Lopez-Gitlitz, A.; Rooney, O. B.; Darif, M.; Small, E. J.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Tumor mutational burden, clinical features, and outcomes to PD-1 mono- and combination therapy in patients with cutaneous and unknown primary melanoma
    Meeting Abstract

    Shoushtari, A. N.; Armenia, J.; Arora, A.; Rojas-Zamalloa, J.; Warner, A. B.; Derr, M.; Postow, M. A.; Callahan, M. K.; Momtaz, P.; Coit, D. G.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Relationship between preoperative geriatric frailty and need for postoperative intensive care unit admission and subsequent short- and long-term mortality
    Meeting Abstract

    Shahrokni, A.; Sarraf, S.; Alexander, K.; Sun, S. W.; Kim, S. J.; McMillan, S.; Yulico, H.; Downey, R. J.; Korc-Grodzicki, B.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save